Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$95,919,389
+$9,680,957 QoQ
Shares Held
377,680
+7.1% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#307
of 4,664 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Harding Loevner LP holds $340,761,986 across 4 Drug Manufacturers - General names. JNJ ranks #1 (28.1% of the industry book) .
All Filings in JNJ
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $95,919,389 | 377,680 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $86,238,432 | 352,800 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $75,542,751 | 365,029 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $78,758,999 | 424,760 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $88,470,050 | 579,182 | Shares | Sole | 2025-08-14 | |
| 2022-09-30 | $11,435 | 70 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $85,706 | 501 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $80,911 | 501 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $82,534 | 501 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $82,339 | 501 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $78,847 | 501 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $74,588 | 501 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $112,504 | 800 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $104,904 | 800 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||